Publicaties | RIVM

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness

Stand van zaken: introductie van vaccinatie tegen baarmoederhalskanker

HPV16/18 vaccinatie en preventie van baarmoederhalskanker: kosteneffectiviteitsanalyses op basis van een simulatiemodel

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study

Primary human papillomavirus DNA screening for cervical cancer prevention

The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: Results from the EPIC Cohort

Gezondheidsraad adviseert HPV-vaccinatie

The National Immunisation Programme in the Netherlands: Surveillance and developments in 2018-2019

The National Immunisation Programme in the Netherlands : Surveillance and developments in 2017-2018